Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00072969
Brief Title: A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

First Submitted : November 12, 2003
First Submitted that Met QC Criteria : November 12, 2003
First Posted : November 13, 2003 (Estimate)

Last Update Submitted that Met QC Criteria : March 3, 2008
Last Update Posted : March 4, 2008 (Estimate)